{"id":734,"date":"2023-10-11T19:30:49","date_gmt":"2023-10-12T02:30:49","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?p=734"},"modified":"2024-03-21T21:40:54","modified_gmt":"2024-03-22T04:40:54","slug":"remarkable-progress-in-clinical-trials-cbt-009-and-cbt-004","status":"publish","type":"post","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/remarkable-progress-in-clinical-trials-cbt-009-and-cbt-004\/","title":{"rendered":"\u81e8\u5e8a\u8a66\u9a57\u53d6\u5f97\u986f\u8457\u9032\u5c55\uff1aCBT-009\u548cCBT-004"},"content":{"rendered":"

Cloudbreak Pharma\uff08\u64a5\u5eb7\u8996\u96f2\uff09\u6b23\u7136\u5ba3\u5e03\u00a0<\/strong><\/p>\n

    \n
  1. \u7528\u65bc\u6cbb\u7642\u9752\u5c11\u5e74\u8fd1\u8996\u7684\u65b0\u85e5CBT-009 \u5df2\u8207FDA\u9054\u6210\u5354\u5b9a\uff0c\u5c07\u5728\u7f8e\u570b\u9032\u51653\u671f\u81e8\u5e8a\u8a66\u9a57\u3002<\/li>\n
  2. \u7528\u65bc\u6cbb\u7642\u5145\u8840\u6027\u7d50\u819c\u9ec3\u6591\u7684\u65b0\u85e5CBT-004\u5728\u7f8e\u570b\u905e\u4ea4\u81e8\u5e8a2\u671f\u7533\u8acb<\/li>\n<\/ol>\n

    CBT-009\u5df2\u8207FDA\u9054\u6210\u5354\u5b9a\uff0c\u5c06\u5728\u7f8e\u570b\u9032\u51653\u671f\u81e8\u5e8a\u8a66\u9a57\u3002<\/h2>\n

    \u64a5\u5eb7\u8996\u96f2\u7684\u6838\u5fc3\u7522\u54c1\u4e4b\u4e00CBT-009\u6ef4\u773c\u6db2\u5df2\u65bc2023\u5e749\u670821\u65e5\u7372\u5f97\u7f8e\u570b\u846f\u76e3\u5c40\u7684\u8a31\u53ef\uff0c \u5c07\u5728\n\u7f8e\u570b\u7387\u5148\u9032\u884c\u81e8\u5e8a3\u671f\u7684\u7814\u7a76\u3002<\/p>\n

    2022\u5e74\uff0c \u5168\u7403\u9752\u5c11\u5e74\uff085 - 19\u6b72\uff09\u8fd1\u8996\u60a3\u8005\u9054\u52305.714\u5104\u4eba\uff0c 2018 - 2022\u5e74\u7684\u8907\u5408\u5e74\u589e\u9577\u7387\u70ba3.1%\uff0c \u4e14\u9810\u8a082027\u5e74\u548c2032\u5e74\u5206\u5225\u9054\u52306.422\u5104\u548c6.907\u5104\u3002 \u800c\u5728 2022 \u5e74\u7f8e\u570b\u9752\u5c11\u5e74\u8fd1\u8996\u60a3\u8005\u4eba\u6578\u9054\u5230 2870 \u842c\uff0c 2018 - 2022 \u5e74\u8907\u5408\u5e74\u589e\u9577\u7387\u70ba 1.0%\uff0c \u4e14\u9810\u8a08\u5230 2027 \u5e74\u5c07\u9054\u5230 2960 \u842c\u4eba\u3002<\/p>\n

    \u963f\u6258\u54c1\u662f\u4e2d\u570b\u570b\u5bb6\u885b\u751f\u5065\u5eb7\u59d4\u767c\u4f48\u7684\u300a\u5152\u7ae5\u9752\u5c11\u5e74\u8fd1\u8996\u9632\u63a7\u9069\u5b9c\u6280\u8853\u6307\u5357\u300b \u4e2d\u63a8\u85a6\u7684\u6cbb\u7642\u9752\u5c11\u5e74\u8fd1\u8996\u7684\u85e5\u7269\u3002 \u76ee\u524d\uff0c \u4f4e\u6fc3\u5ea6\u963f\u6258\u54c1\u6ef4\u773c\u6db2\u662f\u552f\u4e00\u88ab\u8b49\u660e\u80fd\u6301\u7e8c\u6709\u6548\u6e1b\u7de9\u8fd1\u8996\u9032\u5c55\u7684\u6297\u81bd\u9e7c\u85e5\u7269\u6cbb\u7642\u9078\u64c7\u3002 \u7136\u800c\uff0c \u7531\u65bc\u4f4e\u6fc3\u5ea6\u963f\u6258\u54c1\u5728\u6c34\u6027\u88fd\u5291\u4e2d\u4e0d\u7a69\u5b9a\uff0c \u4fdd\u8cea\u671f\u6709\u9650\uff0c \u5c0e\u81f4\u6c34\u6027\u963f\u6258\u54c1\u6ef4\u773c\u6db2\u672a\u80fd\u88ab\u66f4\u5ee3\u6cdb\u7684\u8a8d\u53ef\u70ba\u9752\u5c11\u5e74\u8fd1\u8996\u7684\u6cbb\u7642\u65b9\u5f0f\u3002 \u56e0\u800c\uff0c \u4f4e\u6fc3\u5ea6\u963f\u6258\u54c1\u6ef4\u773c\u6db2\u7684\u4e0d\u7a69\u5b9a\u6027\u9577\u671f\u4ee5\u4f86\u4e00\u76f4\u662f\u5546\u696d\u5316\u7684\u6280\u8853\u969c\u7919\u3002<\/p>\n

    \u64a5\u5eb7\u8996\u96f2\u5728\u570b\u969b\u9996\u5275\u65b0\u578b\u975e\u6c34\u6027\u963f\u6258\u54c1\u6ef4\u773c\u5291CBT-009\uff0c \u8207\u73fe\u6709\u6c34\u6027\u963f\u6258\u54c1\u6ef4\u773c\u6db2\u76f8\u6bd4\uff0c \u88fd\u5291\u7a69\u5b9a\u6027\u5927\u5e45\u5ea6\u63d0\u9ad8\uff0c \u53ef\u4ee5\u986f\u8457\u6e1b\u5c11\u963f\u6258\u54c1\u7684\u964d\u89e3\uff0c \u5f9e\u800c\u6e1b\u5c11\u96dc\u8cea\u7684\u7522\u751f\uff0c \u4f7f\u5f97CBT-009\u5728\u5ba4\u6eab\u751a\u81f3\u9ad8\u6eab\u4e0b\u53ef\u4ee5\u9577\u671f\u4fdd\u5b58\u3002 CBT-009\u6ef4\u773c\u6db2\u672c\u8eab\u5177\u6709\u9632\u6b62\u7d30\u83cc\u751f\u9577\u7684\u80fd\u529b\uff0c \u56e0\u6b64\u4e0d\u9700\u8981\u984d\u5916\u6dfb\u52a0\u9632\u8150\u5291\u6216\u9032\u884c\u7279\u6b8a\u55ae\u5291\u91cf\u5305\u88dd\u3002 \u975e\u6c34\u6027\u963f\u6258\u54c1\u6ef4\u773c\u6db2CBT-009\u6240\u9700\u4f7f\u7528\u7684\u5291\u91cf\u6bd4\u73fe\u6709\u6c34\u6027\u6ef4\u773c\u6db2\u4f4e\uff0c \u53ef\u4ee5\u5747\u52fb\u5206\u4f48\u5728\u6dda\u6db2\u4e0a\u5f9e\u800c\u589e\u52a0\u4e86\u963f\u6258\u54c1\u5728\u773c\u8868\u505c\u7559\u6642\u9593\u53ca\u63d0\u9ad8\u751f\u7269\u5229\u7528\u5ea6\u3002 \u6b64\u5916\uff0c CBT-009\u6ef4\u773c\u6db2\u5177\u5099\u773c\u90e8\u8212\u9069\u6db2\u7684\u529f\u80fd\uff0c \u60a3\u8005\u9ad4\u9a57\u611f\u512a\u7570\uff0c \u5c07\u6703\u986f\u8457\u63d0\u9ad8\u9752\u5c11\u5e74\u60a3\u8005\u91ab\u5f9e\u6027\u3002<\/p>\n

    \u4f5c\u70ba\u64a5\u5eb7\u8996\u96f2\u7684\u6838\u5fc3\u7522\u54c1\u4e4b\u4e00\uff0c \u7121\u6c34\uff0c \u7121\u9632\u8150\u5291\uff0c \u8212\u9069\u7684\u591a\u5291\u91cf\u5305\u88ddCBT-009\u6ef4\u773c\u6db2\u9810\u8a08\u5c07\u986f\u8457\u63d0\u9ad8\u60a3\u8005\u7684\u8010\u53d7\u6027\u3001 \u5b89\u5168\u6027\u3001 \u91ab\u5f9e\u6027\u548c\u7522\u54c1\u7a69\u5b9a\u6027\u3002 \u5728\u7f8e\u570b\u7372\u6279III\u671f\u81e8\u5e8a\u8a31\u53ef\u662f\u5be6\u73fe\u8a72\u85e5\u7269\u5546\u696d\u5316\u7684\u4e00\u500b\u91cd\u8981\u91cc\u7a0b\u7891\uff0c \u4e5f\u662f\u516c\u53f8\u7e7c\u6cbb\u7642\u7ffc\u72c0\u80ec\u8089\u65b0\u85e5CBT-001\u540e\u7b2c\u4e8c\u500b\u81ea\u4e3b\u5275\u65b0\u7522\u54c1\u7372\u6279\u9032\u5165\u7f8e\u570b\u81e8\u5e8a3\u671f\u3002<\/p>\n

    CBT-004\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u5728\u7f8e\u570b\u9032\u884c2\u671f\u81e8\u5e8a\u8a66\u9a57\u7684\u7533\u8acb\u3002<\/h2>\n

    CBT-004\u6ef4\u773c\u6db2\u5df2\u65bc2023\u5e749\u670829\u65e5\u905e\u4ea4\u7f8e\u570b\u846f\u76e3\u5c40\uff0c \u7533\u8acb\u6cbb\u7642\u5145\u8840\u6027\u7d50\u819c\u9ec3\u6591\u7684\u81e8\u5e8a2\u671f\u7814\u7a76\u3002 CBT-004\u662f\u4e00\u7a2e\u5c0f\u5206\u5b50\u591a\u6fc0\u9176\u6291\u88fd\u5291\uff0c \u5728\u975e\u81e8\u5e8a\u85e5\u6548\u52d5\u7269\u6a21\u578b\u4ee5\u53ca\u52d5\u7269\u6bd2\u7406\u5be6\u9a57\u4e2d\u5747\u986f\u793a\u51fa\u826f\u597d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002 \u6839\u64daFrost &Sullivan\u5831\u544a\uff0c \u76ee\u524d\u5168\u7403\u5c1a\u7121\u7372\u6279\u51c6\u7684\u6cbb\u7642\u5145\u8840\u6027\u7d50\u819c\u9ec3\u6591\u7684\u85e5\u7269\u7642\u6cd5\u3002 \u800c\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c2022\u5e74\u7d50\u819c\u9ec3\u6591\u60a3\u8005\u4eba\u6578\u9054\u523011.496\u5104\uff0c 2018\u5e74\u81f32022\u5e74\u8907\u5408\u5e74\u589e\u9577\u7387\u70ba1.2%\u3002 \u9810\u8a082027\u5e74\u5c07\u9054\u523012.171\u5104\uff0c 2032\u5e74\u5c07\u9054\u523012.838\u5104\uff0c2022\u5e74\u52302027\u5e74\u8907\u5408\u5e74\u589e\u9577\u7387\u70ba1.1% \uff0c 2027\u5e74\u52302032\u5e74\u8907\u5408\u589e\u9577\u7387\u70ba1.1%\u3002<\/p>","protected":false},"excerpt":{"rendered":"

    We are proud to announce that\u00a0 CBT-009, our novel ophthalmic formulation of atropine indicated for the treatment of juvenile myopia, has reached agreement with FDA to enter into Phase 3 clinical trial in the USA. We have submitted our application to FDA for conducting a Phase 2 clinical trial in the United States to test […]<\/p>\n","protected":false},"author":16,"featured_media":736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=734"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/734\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media\/736"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/categories?post=734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/tags?post=734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}